Pompe Disease Treatment success with Alglucosidase alfa in the late form of the disease

被引：0
|
作者：
Ecker-Schlipf, Barbara
机构：
来源：
PSYCHOPHARMAKOTHERAPIE | 2010年 / 17卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：255 / 256
页数：2
相关论文
共 50 条
  • [1] BLA filed for alglucosidase alfa in Pompe disease
    不详
    [J]. DRUG NEWS & PERSPECTIVES, 2005, 18 (06) : 374 - 374
  • [2] ALGLUCOSIDASE ALFA IN INFANTS AND CHILDREN WITH POMPE DISEASE
    Kishnani, P.
    Hwu, W. -L.
    Leslie, N.
    Wraith, J.
    Nicolino, M.
    [J]. CLINICAL THERAPEUTICS, 2008, 30 : S114 - S114
  • [3] Alglucosidase alfa in infants and children with Pompe disease
    Wraith, E.
    Byrne, B.
    Hwu, W. L.
    Leslie, N.
    Mandel, H.
    Nicolino, M.
    Kishnani, P. S.
    [J]. NEUROMUSCULAR DISORDERS, 2008, 18 (9-10) : 800 - 800
  • [4] Alglucosidase alfa: 5 years of experience in late-onset Pompe disease
    Benedikt Schoser
    [J]. BMC Musculoskeletal Disorders, 14 (Suppl 2)
  • [5] Alglucosidase alfa and Pompe disease: Still going strong?
    Lipinski, Shawn E.
    [J]. MOLECULAR GENETICS AND METABOLISM, 2012, 107 (03) : 245 - 246
  • [6] Long-term efficacy of alglucosidase alfa in late-onset Pompe disease
    van der Ploeg, Ans
    Clemens, Paula
    Hopkin, Robert J.
    Kacena, Katherine
    Sanson, Bernd-Jan
    Laforet, Pascal
    [J]. MOLECULAR GENETICS AND METABOLISM, 2017, 120 (1-2) : S134 - S134
  • [7] A Randomized Study of Alglucosidase Alfa in Late-Onset Pompe's Disease.
    van der Ploeg, Ans T.
    Clemens, Paula R.
    Corzo, Deyanira
    Escolar, Diana M.
    Florence, Julaine
    Groeneveld, Geert Jan
    Herson, Serge
    Kishnani, Priya S.
    Laforet, Pascal
    Lake, Stephen L.
    Lange, Dale J.
    Leshner, Robert T.
    Mayhew, Jill E.
    Morgan, Claire
    Nozaki, Kenkichi
    Park, Dorothy J.
    Pestronk, Alan
    Rosenbloom, Barry
    Skrinar, Alison
    van Capelle, Carine I.
    van der Beek, Nadine A.
    Wasserstein, Melissa
    Zivkovic, Sasa A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (15): : 1396 - 1406
  • [8] Clinical benefit of treatment with alglucosidase alfa in infants and children with advanced Pompe disease
    Nicolino, M.
    Byrne, B.
    Spencer, C.
    Levine, J.
    Leslie, N.
    Wraith, E.
    Kishnani, P.
    [J]. CLINICAL THERAPEUTICS, 2008, 30 : S33 - S33
  • [9] High antibody titer in an adult with Pompe disease affects treatment with alglucosidase alfa
    de Vries, Juna M.
    van der Beek, Nadine A. M. E.
    Kroos, Marian A.
    Ozkan, Lale
    van Doorn, Pieter A.
    Richards, Susan M.
    Sung, Crystal C. C.
    Brugma, Jan-Dietert C.
    Zandbergen, Adrienne A. M.
    van der Ploeg, Ans T.
    Reuser, Arnold J. J.
    [J]. MOLECULAR GENETICS AND METABOLISM, 2010, 101 (04) : 338 - 345
  • [10] Profile of alglucosidase alfa in the treatment of Pompe disease: safety, efficacy, and patient acceptability
    Schneider, Ilka
    Zierz, Stephan
    [J]. RESEARCH AND REPORTS IN ENDOCRINE DISORDERS, 2016, 6 : 1 - 16
12345